Vivet Therapeutics Doses First Patient in Cohort 2 in Phase 1/2 GATEWAY Clinical Trial for Treatment of Wilson Disease lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Uyen To, MD, assistant professor of medicine (digestive diseases) and transplant hepatologist, discusses how she first became interested in studying Wilson
Orphalan announces publication of results from the CHELATE trial in The Lancet Gastroenterology & Hepatology Trial supported Orphalan's successful application to the United States Food and
Orphalan announces data from secondary analyses of the CHELATE trial for maintenance patients with Wilson's Disease - Data from the company's CHELATE trial to be presented today during an oral presentation